FDA recall D-170-2013

West-ward Pharmaceutical Corp. · Class II · drug

Product

Belladonna Alkaloids (hyoscyamine sulfate, USP 0.1037 mg; atropine sulfate, USP 0.0194 mg; scopolamine HBr, USP 0.0065 mg) with Phenobarbital (USP 16.2 mg) Tablets, packaged in a) 1000-count tablets per bottle (NDC 0143-1140-10; b) 5000-count tablets per bottle (NDC 143-1140-51); Rx only, Manufactured by: West-ward Pharmaceutical Corp. Eatontown, NJ 07724

Reason for recall

Presence of Foreign Substance: Uncharacteristic blacks spots were found in tablets.

Distribution

Nationwide

Key facts

Status
Terminated
Initiation date
2013-01-07
Report date
2013-03-06
Termination date
2015-01-21
Voluntary/Mandated
Voluntary: Firm initiated
Location
Eatontown, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-170-2013